Charlebois ED - Search Results

1

Costs of integrating hypertension care into HIV care in rural East African clinics.

Shade SB, Osmand T, Kwarisiima D, Brown LB, Luo A, Mwebaza B, Mwesigye AR, Kwizera E, Imukeka H, Mwanga F, Ayieko J, Owaraganise A, Bukusi EA, Cohen CR, Charlebois ED, Black D, Clark TD, Petersen ML, Kamya MR, Havlir DV, Jain V. Shade SB, et al. Among authors: charlebois ed. AIDS. 2021 May 1;35(6):911-919. doi: 10.1097/QAD.0000000000002834. AIDS. 2021. PMID: 33821821 Free PMC article.

2

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

3

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. AIDS. 2001 Jun 15;15(9):1181-3. doi: 10.1097/00002030-200106150-00015. AIDS. 2001. PMID: 11416722 No abstract available.

4

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.

Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ. Staedke SG, et al. Among authors: charlebois ed. Lancet. 2001 Aug 4;358(9279):368-74. doi: 10.1016/S0140-6736(01)05557-X. Lancet. 2001. PMID: 11502317 Clinical Trial.

5

Expanding access to early HIV care: new challenges for federal health policy.

Morin SF, Charlebois ED. Morin SF, et al. Among authors: charlebois ed. AIDS Public Policy J. 2000 Summer;15(2):65-74. AIDS Public Policy J. 2000. PMID: 11519368

6

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN, Clark R, Guzman D, Zolopa A, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. AIDS. 2003 Sep 5;17(13):1925-32. doi: 10.1097/00002030-200309050-00011. AIDS. 2003. PMID: 12960825

7

Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.

Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Porco TC, et al. AIDS. 2004 Jan 2;18(1):81-8. doi: 10.1097/00002030-200401020-00010. AIDS. 2004. PMID: 15090833 Free PMC article.

8

Are untimed antiretroviral drug levels useful predictors of adherence behavior?

Liechty CA, Alexander CS, Harrigan PR, Guzman JD, Charlebois ED, Moss AR, Bangsberg DR. Liechty CA, et al. Among authors: charlebois ed. AIDS. 2004 Jan 2;18(1):127-9. doi: 10.1097/00002030-200401020-00017. AIDS. 2004. PMID: 15090840

9

Rapid increase in tuberculosis incidence soon after infection with HIV--a new twist in the twin epidemics.

Srikantiah P, Charlebois E, Havlir DV. Srikantiah P, et al. J Infect Dis. 2005 Jan 15;191(2):147-9. doi: 10.1086/426832. Epub 2004 Dec 13. J Infect Dis. 2005. PMID: 15609222 No abstract available.

10

Antiretroviral therapy and TB.

Swaminathan S, Luetkemeyer A, Srikantiah P, Lin R, Charlebois E, Havlir DV. Swaminathan S, et al. Trop Doct. 2006 Apr;36(2):73-9. doi: 10.1258/004947506776593387. Trop Doct. 2006. PMID: 16611437 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page